JP5324093B2 - 負電荷を有する疎水性基で官能基化された分岐鎖ポリアミノ酸、及びその応用、特に治療への応用 - Google Patents

負電荷を有する疎水性基で官能基化された分岐鎖ポリアミノ酸、及びその応用、特に治療への応用 Download PDF

Info

Publication number
JP5324093B2
JP5324093B2 JP2007523129A JP2007523129A JP5324093B2 JP 5324093 B2 JP5324093 B2 JP 5324093B2 JP 2007523129 A JP2007523129 A JP 2007523129A JP 2007523129 A JP2007523129 A JP 2007523129A JP 5324093 B2 JP5324093 B2 JP 5324093B2
Authority
JP
Japan
Prior art keywords
group
acid
polyamino
hydrophobic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007523129A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008508389A (ja
JP2008508389A5 (https=
Inventor
オリヴィエ ブレイヌ
ゴーティエ プーリケン
ユ−ピン チャン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flamel Technologies SA
Original Assignee
Flamel Technologies SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flamel Technologies SA filed Critical Flamel Technologies SA
Publication of JP2008508389A publication Critical patent/JP2008508389A/ja
Publication of JP2008508389A5 publication Critical patent/JP2008508389A5/ja
Application granted granted Critical
Publication of JP5324093B2 publication Critical patent/JP5324093B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/48—Polymers modified by chemical after-treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Polyamides (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
JP2007523129A 2004-07-30 2005-07-25 負電荷を有する疎水性基で官能基化された分岐鎖ポリアミノ酸、及びその応用、特に治療への応用 Expired - Fee Related JP5324093B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0408478A FR2873704B1 (fr) 2004-07-30 2004-07-30 Polyaminoacides fonctionnalises par des greffons hydrophobes portant une charge anionique et leurs applications notamment therapeutiques
FR0408478 2004-07-30
PCT/FR2005/050610 WO2006021710A1 (fr) 2004-07-30 2005-07-25 Polyaminoacides fonctionnalises par des greffons hydrophobes portant une charge anionique et leurs applications notamment therapeutiques

Publications (3)

Publication Number Publication Date
JP2008508389A JP2008508389A (ja) 2008-03-21
JP2008508389A5 JP2008508389A5 (https=) 2012-08-23
JP5324093B2 true JP5324093B2 (ja) 2013-10-23

Family

ID=34949825

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007523129A Expired - Fee Related JP5324093B2 (ja) 2004-07-30 2005-07-25 負電荷を有する疎水性基で官能基化された分岐鎖ポリアミノ酸、及びその応用、特に治療への応用

Country Status (8)

Country Link
US (1) US20100098656A1 (https=)
EP (1) EP1773914B9 (https=)
JP (1) JP5324093B2 (https=)
AT (1) ATE449806T1 (https=)
CA (1) CA2573612A1 (https=)
DE (1) DE602005017903D1 (https=)
FR (1) FR2873704B1 (https=)
WO (1) WO2006021710A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8304497B2 (en) * 2005-05-02 2012-11-06 The University Of Tokyo Electrostatically bonded polymer vesicle
FR2915684B1 (fr) * 2007-05-03 2011-01-14 Flamel Tech Sa Particules a base de polyelectrolytes et de principe actif a liberation modifiee et formulations pharmaceutiques contenant ces particules
US7999040B2 (en) 2007-09-25 2011-08-16 Nanochem Solutions, Inc. Method of making graft copolymers from sodium poly(aspartate) and the resulting graft copolymer
WO2009041913A1 (en) * 2007-09-26 2009-04-02 Thorsson Limited Colloidal fertilizer and related methods
US20110060123A1 (en) * 2008-04-30 2011-03-10 Kazunori Kataoka Charge conversional ternary polyplex
US20130105377A1 (en) 2010-02-10 2013-05-02 Queen's University At Kingston Water with Switchable Ionic Strength
JP2013234207A (ja) * 2010-08-31 2013-11-21 Jsr Corp 新規重合体及び新規ｎ−カルボキシアミノ酸無水物、ならびにそれらの製造方法
AU2011342287B2 (en) * 2010-12-15 2015-09-17 Greencentre Canada Systems and methods for use of water with switchable ionic strength
CN111698999A (zh) * 2017-12-06 2020-09-22 阿道恰公司 包含至少一种pi在5.8与8.5之间的基础胰岛素和带有羧酸根电荷及疏水基的共聚氨基酸的ph为7的可注射溶液
WO2019110788A1 (fr) 2017-12-07 2019-06-13 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide
MA51127A (fr) 2017-12-07 2021-03-17 Adocia Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes
SG11202005319PA (en) * 2017-12-07 2020-07-29 Adocia Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a copolyamino acid
WO2019110797A1 (fr) * 2017-12-07 2019-06-13 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide
CA3084688A1 (fr) 2017-12-07 2019-06-13 Adocia Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes
CN109498548B (zh) * 2018-12-11 2021-09-24 吉林化工学院 一种蛋白质与光敏剂共传递pH响应性聚氨基酸纳米凝胶及其制备方法
US20250073176A1 (en) * 2021-03-18 2025-03-06 Agfa-Gevaert Nv Poly(amino acid) based capsules

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351337A (en) * 1973-05-17 1982-09-28 Arthur D. Little, Inc. Biodegradable, implantable drug delivery device, and process for preparing and using the same
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
ATE60340T1 (de) * 1984-10-19 1991-02-15 Battelle Memorial Institute Durch mikroorganismen abbaubares polypeptid und seine verwendung fuer die fortschreitende abgabe von medikamenten.
CH667874A5 (fr) * 1985-12-19 1988-11-15 Battelle Memorial Institute Polypeptide synthetique biodegradable et son utilisation pour la preparation de medicaments.
KR940003548U (ko) * 1992-08-14 1994-02-21 김형술 세탁물 건조기
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
FR2732218B1 (fr) * 1995-03-28 1997-08-01 Flamel Tech Sa Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s) et leurs procedes de preparation
FR2786098B1 (fr) * 1998-11-20 2003-05-30 Flamel Tech Sa Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s), suspension colloidale les comprenant et leurs procedes de fabrication
WO2003014193A1 (en) * 2001-08-03 2003-02-20 The Procter & Gamble Company Polyaspartate derivatives for use in detergent compositions
JP2003327693A (ja) * 2002-05-15 2003-11-19 Mitsuru Akashi 親−疎水性修飾ポリ（γ−グルタミン酸）
FR2840614B1 (fr) * 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
WO2004060968A1 (fr) * 2002-12-04 2004-07-22 Flamel Technologies Polyaminoacides fonctionnalises par au moins un groupement (oligo)aminoacide et leurs applications notamment therapeutiques
FR2855521B1 (fr) * 2003-05-28 2005-08-05 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
FR2873703B1 (fr) * 2004-07-30 2006-12-08 Flamel Technologies Sa Polyaminoacides branches, fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques

Also Published As

Publication number Publication date
DE602005017903D1 (de) 2010-01-07
WO2006021710A1 (fr) 2006-03-02
JP2008508389A (ja) 2008-03-21
EP1773914A1 (fr) 2007-04-18
EP1773914B1 (fr) 2009-11-25
ATE449806T1 (de) 2009-12-15
EP1773914B9 (fr) 2010-03-31
FR2873704B1 (fr) 2006-12-08
US20100098656A1 (en) 2010-04-22
FR2873704A1 (fr) 2006-02-03
CA2573612A1 (fr) 2006-03-02

Similar Documents

Publication Publication Date Title
JP4896723B2 (ja) 少なくとも１つの疎水性基で官能化されたポリアミノ酸及びその応用、特に治療用応用
KR100972264B1 (ko) 알파 토코페롤에 의하여 관능화된 폴리아미노산 및 특히치료용을 위한 이의 용도
US7678882B2 (en) Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof
JP4970731B2 (ja) 少なくとも１つの（オリゴ）アミノ酸基によって官能性をもたせたポリアミノ酸およびこれらの適用、特に医療適用
JP5324093B2 (ja) 負電荷を有する疎水性基で官能基化された分岐鎖ポリアミノ酸、及びその応用、特に治療への応用
JP4897485B2 (ja) 疎水性基で官能化されたテレケリックホモポリアミノ酸、およびその用途、特に治療用途
JP2010529214A (ja) カチオン性基及び疎水性基により官能基化したポリグルタミン酸及びその応用、特にはその治療への応用
US20110044930A1 (en) Copolyhydroxyalkylglutamines functionalised with hydrophobic groups, and uses thereof, especially in therapeutics
JP5292099B2 (ja) ヒスチジン誘導体および疎水基で官能化されたポリグルタミン酸類、ならびに特に治療目的のためのそれらの使用
JP4871867B2 (ja) 疎水性基で官能基化された分岐鎖ポリアミノ酸、及びその応用、特に治療への応用
HK1124353A (en) Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080711

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120207

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120424

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120502

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120607

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120614

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20120704

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130312

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130611

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130709

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130718

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees